Publication:
N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity

dc.contributor.authorMayumi Tachibanaen_US
dc.contributor.authorYimin Wuen_US
dc.contributor.authorHideyuki Irikoen_US
dc.contributor.authorOlga Muratovaen_US
dc.contributor.authorNicholas J. MacDonalden_US
dc.contributor.authorJetsumon Sattabongkoten_US
dc.contributor.authorSatoru Takeoen_US
dc.contributor.authorHitoshi Otsukien_US
dc.contributor.authorMotomi Toriien_US
dc.contributor.authorTakafumi Tsuboien_US
dc.contributor.otherEhime Universityen_US
dc.contributor.otherNational Institute of Allergy and Infectious Diseasesen_US
dc.contributor.otherTottori Universityen_US
dc.contributor.otherArmed Forces Research Institute of Medical Sciences, Thailanden_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-05-03T08:01:29Z
dc.date.available2018-05-03T08:01:29Z
dc.date.issued2011-08-01en_US
dc.description.abstractThe aim of a malaria transmission-blocking vaccine is to block the development of malaria parasites in the mosquito and thus prevent subsequent infection of the human host. Previous studies have demonstrated that the gametocyte/gamete surface protein Pfs230 can induce transmission-blocking immunity and have evaluated Escherichia coli-produced Pfs230 as a transmission-blocking vaccine candidate. In this study, we used the wheat germ cell-free expression system to produce N-terminal fragments of Pfs230 and evaluated the transmission-blocking activity of antisera raised against the recombinant Pfs230 protein. The rabbit antisera reacted to the surface of cultured gametocytes and gametes of the Plasmodium falciparum NF54 line, recognized the 360-kDa form of parasite-produced Pfs230 by Western blot assay, and reduced the infectivity of NF54 parasites to Anopheles stefensi mosquitoes in the presence of complement in a standard membrane feeding assay. Thus, our data demonstrate that the N-terminal pro domain of Pfs230 is sufficient to induce complement-dependent transmission-blocking activity against P. falciparum. Copyright © 2011, American Society for Microbiology. All Rights Reserved.en_US
dc.identifier.citationClinical and Vaccine Immunology. Vol.18, No.8 (2011), 1343-1350en_US
dc.identifier.doi10.1128/CVI.05104-11en_US
dc.identifier.issn1556679Xen_US
dc.identifier.issn15566811en_US
dc.identifier.other2-s2.0-79961122590en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/11507
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79961122590&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectImmunology and Microbiologyen_US
dc.subjectMedicineen_US
dc.titleN-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activityen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79961122590&origin=inwarden_US

Files

Collections